| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 7.529 | 33.588 | 22.242 | 41.033 | 53.528 | 23.373 | 48.958 |
| Total Income - EUR | - | - | - | 7.549 | 34.417 | 23.324 | 45.978 | 61.615 | 27.413 | 49.303 |
| Total Expenses - EUR | - | - | - | 11 | 2.272 | 5.517 | 5.095 | 7.909 | 14.282 | 24.208 |
| Gross Profit/Loss - EUR | - | - | - | 7.538 | 32.145 | 17.808 | 40.884 | 53.706 | 13.131 | 25.095 |
| Net Profit/Loss - EUR | - | - | - | 7.312 | 31.137 | 17.160 | 39.712 | 52.069 | 11.257 | 24.659 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Ecso Labs S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 1.207 | 692 | 1.649 | 20.870 |
| Current Assets | - | - | - | 7.581 | 32.557 | 20.391 | 47.831 | 52.377 | 31.163 | 20.738 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 594 | 0 |
| Receivables | - | - | - | 7.538 | 28.934 | 19.068 | 44.580 | 49.939 | 29.356 | 20.019 |
| Cash | - | - | - | 43 | 3.622 | 1.323 | 3.251 | 2.438 | 1.213 | 719 |
| Shareholders Funds | - | - | - | 7.355 | 31.188 | 19.512 | 46.024 | 52.117 | 24.391 | 38.476 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 226 | 1.369 | 879 | 3.013 | 952 | 8.421 | 3.132 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6311 - 6311" | |||||||||
| CAEN Financial Year |
6311
|
|||||||||
Comments - Ecso Labs S.r.l.